Stock listing
Frankfurt:37S Spineway SA Aktie
German listing (Frankfurt) of Spineway SA · home listing Euronext:ALSPW
Follow Spineway SA into a list and get an email when it puts out news.
Share price · FWB:37S
€0.089 EUR -0.001 (-1.4%)
Close on Nov 20, 2026
- Day range
- €0.089 – €0.089 EURNov 20, 2026
- Volume
- 1,000 sharesNov 20, 2026
- Market cap
- €3.15M EURAt the close on Nov 20, 2026 · price × 35.54M shares outstanding
- 52-week range
- €0.079 – €0.208 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €723 EURMedian day 0 shares · 44 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:ALSPW · Home | €0.093 EUR | -0.002 (-1.6%) | 7,311 | €0.096 | €0.096 | €0.093 | €0.095 | Close on Nov 20, 2026 |
| Frankfurt:37S | €0.089 EUR | -0.001 (-1.4%) | 1,000 | €0.089 | €0.089 | €0.089 | €0.090 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:37S · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €0.090 | +0.001 | +1.1% | €0.088 | €0.090 | €0.088 | 0 | |
| €0.089 | -0.006 | -6.3% | €0.082 | €0.089 | €0.082 | 0 | |
| €0.095 | +0.013 | +15.9% | €0.081 | €0.096 | €0.079 | 1,000 | |
| €0.082 | 0.000 | 0.0% | €0.081 | €0.082 | €0.081 | 0 | |
| €0.082 | -0.001 | -1.2% | €0.082 | €0.082 | €0.082 | 0 | |
| €0.083 | -0.004 | -4.6% | €0.084 | €0.085 | €0.083 | 0 | |
| €0.087 | +0.002 | +2.4% | €0.084 | €0.087 | €0.084 | 0 | |
| €0.085 | +0.001 | +1.2% | €0.085 | €0.085 | €0.084 | 142,200 | |
| €0.084 | -0.001 | -1.2% | €0.083 | €0.084 | €0.083 | 0 | |
| €0.085 | -0.002 | -2.3% | €0.087 | €0.088 | €0.085 | 17,992 | |
| €0.087 | 0.000 | 0.0% | €0.086 | €0.087 | €0.086 | 0 | |
| €0.087 | 0.000 | 0.0% | €0.086 | €0.088 | €0.086 | 0 | |
| €0.087 | 0.000 | 0.0% | €0.086 | €0.087 | €0.086 | 0 | |
| €0.087 | -0.006 | -6.5% | €0.093 | €0.093 | €0.087 | 0 | |
| €0.093 | +0.003 | +3.3% | €0.093 | €0.093 | €0.092 | 0 | |
| €0.090 | -0.023 | -20.4% | €0.090 | €0.090 | €0.090 | 0 | |
| €0.113 | +0.003 | +2.7% | €0.114 | €0.126 | €0.113 | 1,000 | |
| €0.110 | -0.003 | -2.7% | €0.108 | €0.110 | €0.106 | 0 | |
| €0.113 | +0.007 | +6.6% | €0.108 | €0.114 | €0.107 | 0 | |
| €0.106 | +0.007 | +7.1% | €0.103 | €0.106 | €0.102 | 0 | |
| €0.099 | +0.001 | +1.0% | €0.098 | €0.099 | €0.098 | 0 | |
| €0.098 | +0.002 | +2.1% | €0.096 | €0.098 | €0.095 | 6,800 | |
| €0.096 | +0.004 | +4.3% | €0.095 | €0.098 | €0.095 | 0 | |
| €0.092 | -0.002 | -2.1% | €0.094 | €0.095 | €0.092 | 0 | |
| €0.094 | -0.005 | -5.1% | €0.095 | €0.095 | €0.091 | 0 | |
| €0.099 | 0.000 | 0.0% | €0.100 | €0.100 | €0.097 | 109,038 | |
| €0.099 | -0.002 | -2.0% | €0.099 | €0.100 | €0.099 | 0 | |
| €0.101 | +0.001 | +1.0% | €0.103 | €0.103 | €0.101 | 13,930 | |
| €0.100 | -0.006 | -5.7% | €0.102 | €0.105 | €0.100 | 0 | |
| €0.106 | 0.000 | 0.0% | €0.103 | €0.106 | €0.103 | 0 | |
| €0.106 | +0.001 | +1.0% | €0.106 | €0.106 | €0.106 | 19,640 | |
| €0.105 | -0.004 | -3.7% | €0.106 | €0.107 | €0.105 | 0 | |
| €0.109 | +0.002 | +1.9% | €0.108 | €0.109 | €0.108 | 0 | |
| €0.107 | -0.005 | -4.5% | €0.104 | €0.108 | €0.104 | 0 | |
| €0.112 | -0.002 | -1.8% | €0.112 | €0.113 | €0.112 | 0 | |
| €0.114 | -0.002 | -1.7% | €0.114 | €0.114 | €0.114 | 0 | |
| €0.116 | +0.001 | +0.9% | €0.116 | €0.117 | €0.115 | 0 | |
| €0.115 | +0.002 | +1.8% | €0.114 | €0.116 | €0.113 | 0 | |
| €0.113 | -0.004 | -3.4% | €0.116 | €0.116 | €0.112 | 0 | |
| €0.117 | +0.002 | +1.7% | €0.117 | €0.117 | €0.115 | 0 | |
| €0.115 | -0.001 | -0.9% | €0.116 | €0.116 | €0.115 | 0 | |
| €0.116 | -0.001 | -0.9% | €0.116 | €0.116 | €0.116 | 0 | |
| €0.117 | +0.003 | +2.6% | €0.116 | €0.117 | €0.115 | 0 | |
| €0.114 | -0.001 | -0.9% | €0.114 | €0.114 | €0.114 | 0 | |
| €0.115 | -0.005 | -4.2% | €0.116 | €0.116 | €0.115 | 0 | |
| €0.120 | +0.001 | +0.8% | €0.118 | €0.120 | €0.118 | 73,600 | |
| €0.119 | +0.001 | +0.8% | €0.118 | €0.119 | €0.118 | 0 | |
| €0.118 | -0.002 | -1.7% | €0.119 | €0.119 | €0.117 | 0 | |
| €0.120 | -0.001 | -0.8% | €0.120 | €0.120 | €0.120 | 0 | |
| €0.121 | -0.001 | -0.8% | €0.121 | €0.121 | €0.120 | 0 | |
| €0.122 | -0.002 | -1.6% | €0.122 | €0.123 | €0.121 | 8,530 | |
| €0.124 | 0.000 | 0.0% | €0.126 | €0.126 | €0.123 | 0 | |
| €0.124 | -0.002 | -1.6% | €0.125 | €0.125 | €0.124 | 0 | |
| €0.126 | +0.001 | +0.8% | €0.125 | €0.139 | €0.125 | 100 | |
| €0.125 | -0.001 | -0.8% | €0.124 | €0.125 | €0.123 | 0 | |
| €0.126 | 0.000 | 0.0% | €0.126 | €0.126 | €0.126 | 20,000 | |
| €0.126 | -0.003 | -2.3% | €0.125 | €0.140 | €0.125 | 170 |
Splits
2 splits since 2022 · FWB:37S · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-2000 | Consolidation | |
| 1-for-40000 | Consolidation |
- Ticker
- Frankfurt:37S
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Oct 15, 2026
Nine-month revenue
Latest news
Nine-month revenue
Oct 15, 2026
Closed €0.113 (+2.7%) on Oct 15, 2026
H1 2026 results
Jul 29, 2026
Closed €0.129 (0.0%) on Jul 30, 2026
SPINEWAY:
Apr 29, 2026
Closed €0.157 (+7.5%) on Apr 30, 2026
Minutes of the General Meeting of April 2, 2026
Apr 7, 2026
Closed €0.151 (+1.3%) on Apr 7, 2026
Compte-rendu de l’Assemblée Générale du 2 avril 2026
Apr 6, 2026
Closed €0.151 (+1.3%) on Apr 7, 2026
2025 annual results
Feb 17, 2026
Closed €0.168 (-7.2%) on Feb 18, 2026
2025 revenue of €12.4 million, with an acceleration of sales in Q4 2025 (+34%)
Jan 13, 2026
Closed €0.178 (+2.9%) on Jan 14, 2026
Spineway SA on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 7 in the last 12 months · 12 in all · newest Oct 15, 2026 · oldest 2025
- Decks
- 6 decks · latest Feb 8, 2024
Where Spineway SA is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:ALSPW · Home listing | Euronext | France | EUR |
| gettex:37S | gettex | Germany | EUR |
| LS Exchange:A400E3 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A400E3 | Lang & Schwarz | Germany | EUR |
| Stuttgart:37S | Stuttgart | Germany | EUR |
| Frankfurt:37S · This page | Frankfurt | Germany | EUR |
| Munich:37S | Munich | Germany | EUR |
| Turquoise:ALSPWP | Turquoise | United Kingdom | EUR |
Valuation
EV/sales 0.1× against a median of 0.4×: 3rd lowest of 9 Medical devices & supplies companies shown. Statements: Year to Dec 31, 2025 · price Nov 20, 2026
- Enterprise value
- €1.33M EUR
- P/E
- Loss
- EV/sales
- 0.1×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 0.1×
- Gross margin
- 26.3%
- Operating margin
- −17.2%
- Net margin
- −18.0%
- Debt to equity
- 0.1×
- Beta
- No index for this market yet
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Spineway SA · EURONEXT:ALSPW | US$3.63M | US$1.47M | n/a | 0.1× | n/a | 0.1× | −18.0% | 0.1× | n/a |
| Regentis Biomaterials Ltd. · AMEX:RGNT | US$5.05M | −US$3.90M | n/a | n/a | n/a | 0.7× | n/a | 0.0× | 2.00 |
| SeaStar Medical Holding Corporation · NASDAQ:ICU | US$4.97M | US$981,429 | n/a | 0.5× | n/a | 10.6× | −678.2% | 0.0× | 1.44 |
| WORK Medical Technology Group LTD · NASDAQ:WOK | US$4.84M | US$8.21M | n/a | 0.8× | n/a | 0.2× | −10.9% | 0.2× | 2.76 |
| Kelyniam Global, Inc. · OTC:KLYG | US$4.56M | US$4.84M | n/a | 1.4× | 31.9× | 6.6× | −6.0% | 0.6× | 1.15 |
| Meihua International Medical Technologies Co., Ltd. · OTC:MHUAF | US$4.53M | −US$1.63M | 0.7× | −0.0× | −0.2× | 0.0× | 11.0% | 0.1× | 0.62 |
| Aurora Spine Corp. · TSXV:ASG | US$4.36M | US$6.91M | n/a | 0.4× | 45.6× | 1.5× | −7.0% | 1.0× | -0.13 |
| IceCure Medical Ltd. · NASDAQ:ICCM | US$3.71M | −US$3.80M | n/a | −1.0× | n/a | 0.4× | −439.7% | 0.1× | 1.98 |
| enVVeno Medical Corporation · NASDAQ:NVNO | US$3.65M | −US$14.82M | n/a | n/a | n/a | 0.2× | n/a | 0.0× | 1.12 |
| Baird Medical Investment Holdings Ltd · NASDAQ:BDMD | US$2.88M | US$16.81M | n/a | 0.8× | n/a | 0.1× | −121.0% | 0.4× | -0.13 |
| ScandiDos AB · OMXSTO:SDOS | US$2.85M | US$1.51M | n/a | 0.3× | n/a | 0.6× | −16.4% | 0.1× | n/a |
| Median of the others | US$4.45M | US$1.24M | 0.7× | 0.4× | 31.9× | 0.5× | −13.7% | 0.1× | 1.15 |
Forecasts
Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.
- Price target
- 0.21 EUR · Analysts' mean
- EPS, year to Dec 2026
- -0.060 · 1 analyst
- Revenue, year to Dec 2026
- 13.2M · 1 analyst
Team and board
| Officer | Role |
|---|---|
| Stéphane Le Roux | President |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q4 2025 | Feb 17, 2026 | −17.2% |
| Q2 2025 | Jul 31, 2025 | +8.0% |
| Quarter to Mar 31, 2025 | Jun 4, 2025 | +12.3% |
| Quarter to Sep 30, 2024 | Oct 15, 2024 | +5.1% |
| Q2 2024 | Jul 15, 2024 · After close | −9.8% |
| Quarter to Mar 31, 2024 | Apr 16, 2024 · After close | −4.2% |
| Quarter to Sep 30, 2023 | Oct 13, 2023 · After close | +12.5% |
| Q2 2023 | Jul 11, 2023 · After close | −12.6% |
| Q1 2023 | May 29, 2023 · After close | +15.0% |
| Q4 2022 | Feb 10, 2023 · After close | −7.9% |
All 18 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q3 2022 | Oct 14, 2022 · Before open | −5.4% |
| Q2 2022 | Sep 7, 2022 · After close | 0.0% |
| Q1 2022 | Apr 15, 2022 · Before open | 0.0% |
| Q4 2021 | Jan 18, 2022 · After close | −11.1% |
| Q3 2021 | Oct 14, 2021 · After close | −12.5% |
| Q2 2021 | Jul 13, 2021 · After close | 0.0% |
| Q1 2021 | Apr 16, 2021 · After close | −5.9% |
| Q4 2020 | Jan 25, 2021 · After close | +9.1% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (February 2024) | Investor deck | 26 slides | Feb 8, 2024 |
| FY2018 Earnings Presentation | Earnings | 23 slides | Apr 30, 2019 |
| FY2018 Earnings Presentation | Earnings | 23 slides | Apr 30, 2019 |
| FY2016 Earnings Presentation | Earnings | 22 slides | June 2017 |
| Investor Presentation (2014) | Investor deck | 30 slides | Dec 17, 2014 |
| Investor Presentation (October 2014) | Investor deck | 30 slides | October 2014 |
Financials
Annual, in EUR
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.4M | 11.9M | 10.5M | 7.43M | 4.29M | 3.38M | 5.59M | 6.91M | 9.59M | 5.09M |
| Cost of revenue | 9.16M | 8.59M | 8.89M | 7.20M | 5.74M | 5.50M | 3.69M | 5.03M | 5.86M | 3.94M |
| Gross profit | 3.27M | 3.36M | 1.63M | 237.0K | -1.45M | -2.12M | 1.90M | 1.88M | 3.72M | 1.15M |
| Research and development | 938.2M | 1.52M | ||||||||
| Selling, general and administrative | 5.05M | 5.84M | 5.02M | 1.80M | 2.09M | 2.08M | 3.61M | 3.51M | 2.37M | |
| Operating income | -2.13M | -5.77M | -4.52M | -6.42M | -1.21M | -1.48M | -2.33M | -3.88M | -845.0K | -2.26M |
| Depreciation and amortization | 1.01M | 934.0K | 859.0K | 565.0K | 490.0K | 646.0K | 810.0K | 737.0K | 768.0K | 777.5K |
| EBITDA | -1.12M | -4.84M | -3.66M | -5.86M | -719.0K | -830.0K | -1.51M | -3.14M | -77.0K | -1.48M |
| Interest expense | 316.0K | 2.46M | 1.03M | 38.0K | 58.0K | 12.3M | 194.0K | 737.0K | 124.0K | 100.5K |
| Income before tax | -2.39M | -4.45M | -6.51M | -3.14M | -1.76M | -14.3M | -2.88M | -4.12M | -965.0K | -2.69M |
| Income tax | -149.0K | -581.0K | -1.00K | -226.0K | -173.0K | -231.0K | -210.0K | -396.0K | -448.0K | -451.1K |
| Net income | -2.24M | -3.86M | -6.51M | -3.14M | -1.58M | -14.0M | -2.88M | -4.12M | -965.0K | -2.69M |
| Earnings per share, basic | -0.06 | -0.01 | -816.71 | -5.48 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 3.50M | 4.52M | 1.80M | 5.50M | 13.9M | 4.86M | 2.58M | 141.0K | 2.39M | 1.45M |
| Short-term investments | -68.0K | 5.00M | -237.9K | 1.42M | ||||||
| Receivables | 3.21M | 3.30M | 3.02M | 1.88M | 2.03M | 1.30M | 1.29M | 1.69M | 1.96M | 2.24M |
| Inventory | 4.81M | 4.73M | 4.40M | 3.93M | 2.42M | 2.02M | 2.58M | 3.36M | 3.27M | 3.52M |
| Current assets | 12.8M | 13.9M | 10.2M | 12.1M | 18.4M | 8.18M | 6.82M | 5.87M | 8.37M | 8.17M |
| Property, plant and equipment | 2.53M | 2.40M | 1.92M | 384.0K | 548.0K | 898.0K | 1.27M | 1.06M | 971.0K | |
| Goodwill | 5.90M | 5.90M | 5.40M | 5.40M | 507.0K | |||||
| Total assets | 29.5M | 30.4M | 26.3M | 27.7M | 25.6M | 14.7M | 12.8M | 7.43M | 9.91M | 9.45M |
| Accounts payable | 1.89M | 984.0K | 1.61M | 2.54M | 1.21M | 848.0K | 1.16M | 1.37M | 1.82M | 2.28M |
| Current liabilities | 4.43M | 4.23M | 5.30M | 4.82M | 3.35M | 3.11M | 5.25M | 5.15M | 5.07M | 3.67M |
| Long-term debt | 1.50M | 1.64M | 1.64M | 856.0K | 1.09M | 1.51M | 420.7K | 2.11M | 2.34M | 4.12M |
| Total debt | 1.53M | 1.82M | 2.60M | 1.43M | 3.17M | 3.08M | 4.61M | 4.23M | 5.56M | 4.32M |
| Total liabilities | 6.40M | 6.17M | 7.26M | 5.69M | 4.69M | 4.73M | 6.28M | 6.49M | 8.14M | 8.15M |
| Shareholders' equity | 23.1M | 24.2M | 19.1M | 22.0M | 20.9M | 10.0M | 6.49M | 945.0K | 1.77M | 1.30M |
| Shares outstanding | 35.5M | 278.8M | 7.97K | 572.6K | 166 | 37 | 1 | 0 | 0 | 0 |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 424.0K | -3.27M | -5.83M | -1.62M | -1.79M | -408.0K | -1.16M | -3.41M | -922.0K | -198.0K |
| Capital spending | -424.0K | -3.27M | -1.46M | -12.3M | -1.08M | -981.0K | -5.21M | -1.02M | -1.01M | -768.0K |
| Free cash flow | -163.0K | -3.27M | -7.29M | -13.9M | -2.88M | -1.39M | -6.37M | -4.43M | -1.93M | -966.0K |
| Cash from investing | -1.17M | -1.01M | -1.39M | -10.2M | -578.0K | -979.0K | -5.21M | -952.0K | -1.01M | -758.0K |
| Cash from financing | -269.0K | 7.01M | 3.49M | 3.72M | 11.5M | 3.67M | 8.96M | 2.18M | 2.73M | 1.02M |
| Dividends paid | -746.0K | -2.87M | ||||||||
| Share buybacks | -199.0K | 4.00M | -746.0K | -800.0K | -1.09M | -30.0K | 1.57M | 1.32M | ||
| Change in cash | -1.02M | 2.72M | -3.73M | -8.39M | 9.03M | 2.28M | 2.56M | -2.22M | 783.0K | 65.0K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Spineway : NINE-MONTH REVENUE | Oct 15, 2026 | Results | Euronext |
| Spineway : H1 2026 results | Jul 29, 2026 | Other filings | Euronext |
| SPINEWAY : | Apr 29, 2026 | Results | Euronext |
| SPINEWAY : Compte-rendu de l’Assemblée Générale du 2 avril 2026 | Apr 6, 2026 | Meeting outcome | Euronext |
Cap table
Built by 6ix from Spineway SA’s releases
- Common shares
- 35,544,391
- Fully diluted
- 35,544,391
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 35,544,391 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 35,544,391 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Stéphane Le Roux | President · Since at least Apr 7, 2026 |
Log in to ask 6ix AI your own questions about Spineway SA.